Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Guselkumab”

89 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 89 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05242484
What this trial is testing

Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 577
Large-scale testing (Phase 3)Study completedNCT03796858
What this trial is testing

Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) Therapy

Who this might be right for
Arthritis, Psoriatic
Janssen Pharmaceutica N.V., Belgium 285
Large-scale testing (Phase 3)Study completedNCT02905331
What this trial is testing

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 78
Post-approval studies (Phase 4)Study completedNCT04914429
What this trial is testing

Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 327
Testing effectiveness (Phase 2)Study completedNCT03662542
What this trial is testing

Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 214
Testing effectiveness (Phase 2)Study completedNCT04061395
What this trial is testing

Guselkumab for Hidradenitis Suppurativa, a Mode of Action Study.

Who this might be right for
Hidradenitis Suppurativa
University Medical Center Groningen 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05528510
What this trial is testing

Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 418
Large-scale testing (Phase 3)Active Not RecruitingNCT04033445
What this trial is testing

Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Janssen Research & Development, LLC 1,064
Not applicableLooking for participantsNCT07245394
What this trial is testing

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

Who this might be right for
Inflammatory Bowel Disease (IBD)Crohn Disease (CD)Ulcerative Colitis (UC)+1 more
TIDHI Innovation Inc. 200
Very early researchWithdrawnNCT04084665
What this trial is testing

Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.

Who this might be right for
Hidradenitis Suppurativa
Rockefeller University
Testing effectiveness (Phase 2)Ended earlyNCT04633447
What this trial is testing

Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis

Who this might be right for
Giant Cell Arteritis
Janssen Research & Development, LLC 53
Testing effectiveness (Phase 2)Study completedNCT02319759
What this trial is testing

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)

Who this might be right for
Psoriatic Arthritis
Janssen Research & Development, LLC 149
Large-scale testing (Phase 3)Study completedNCT03158285
What this trial is testing

A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 741
Large-scale testing (Phase 3)Study completedNCT04397263
What this trial is testing

Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohns Disease
Janssen Pharmaceutical K.K. 38
Not applicableLooking for participantsNCT07034664
What this trial is testing

IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study

Who this might be right for
Crohn's DiseaseGuselkumabIntestinal Ultrasound+1 more
The Third Xiangya Hospital of Central South University 50
Post-approval studies (Phase 4)Ended earlyNCT04533737
What this trial is testing

Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab

Who this might be right for
Plaque PsoriasisPsoriasis VulgarisPsoriasis
LEO Pharma 113
Early research (Phase 1)Study completedNCT03536325
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of Guselkumab Following a Single Intravenous Administration in Healthy Japanese Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 24
Large-scale testing (Phase 3)Study completedNCT05272150
What this trial is testing

Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis

Who this might be right for
Plaque PsoriasisScalp Psoriasis
Janssen Research & Development, LLC 213
Large-scale testing (Phase 3)Study completedNCT06039189
What this trial is testing

Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis

Who this might be right for
Moderate Plaque Psoriasis
Janssen Research & Development, LLC 338
Post-approval studies (Phase 4)Not Yet RecruitingNCT06916390
What this trial is testing

GUselkumAb inteRvention and DIet evaluAtioN for Pouchitis

Who this might be right for
Pouchitis
Universitaire Ziekenhuizen KU Leuven 20
Load More Results